首页> 外文会议>International Conference of CELSciTech - Sciences and Technology Track >Isolation, Characterization, in Vitro and in Silico Antidiabetic Activity of Bioactive Compound of Katemas Leaves (Euphorbia Heterophylla, L.)
【24h】

Isolation, Characterization, in Vitro and in Silico Antidiabetic Activity of Bioactive Compound of Katemas Leaves (Euphorbia Heterophylla, L.)

机译:Katemas叶片生物活性化合物的分离,表征,体外和硅抗糖尿病活性(大戟属Heterophylla,L.)

获取原文

摘要

The purpose of this study is to isolate, purify and characterize active compounds from E. heterophylla L. plants and to know the antidiabetic activity of pure Katemas (E.heterophylla, L.) leaf compounds in vitro and in silico (molecular docking) through inhibition of alpha glucosidase enzymes. In this study sample extraction was carried out using multilevel maceration, starting with n-hexane, then with ethyl acetate. Isolation was done by VLC. Antidiabetic activity was tested for pure compounds through inhibition of the α-glucosidase enzyme in vitro using a microplate reader and in silico (molecular docking) using Discovery Studio 4.1 software. VLC results from the ethyl acetate extract of katemas leaves obtained 21 fractions and taken f2 because of the potential for more and stable crystals. F2 is predicted to be a DS-01 diterpenoid compound according to the results of UV, IR, H~1-NMR, C~(13)-NMR and MS spectroscopy. The results of antidiabetic activity test in vitro obtained IC_(50) values of 138.63 μg/mL for ethyl acetate extract and IC_(50) values of 191.82 μg/mL for diterpenoid DS-01 compounds. The results of molecular docking showed that the active compounds contained in the extract and also DS-01 diterpenoids were able to form hydrogen bonds between the ligand with the receptor, but less when compared with the acarbose.
机译:本研究的目的是分离,纯化和表征来自E. heterophylla L.植物的活性化合物,并在体外和硅(分子对接)中的纯Katemas(E.Herophylla,L.)叶化合物的抗糖尿病活性α葡萄糖苷酶的抑制作用。在该研究中,使用多级浸渍进行样品萃取,从N-己烷开始,然后用乙酸乙酯进行。 vlc进行了分离。使用Discovery Studio 4.1软件在体外抑制α-葡糖苷酶和硅(分子对接)来测试纯化合物的抗糖尿病活性。使用Discovery Studio 4.1软件。乙酰乙酸乙酸乙酯提取物的VLC得到的叶片叶片获得21个级分并采取F2,因为晶体较稳定。预计F2是根据UV,IR,H〜1-NMR,C〜(13)-NMR和MS光谱的结果的DS-01二萜化合物。抗糖尿病活性试验的结果在体外获得IC_(50)的乙酸乙酯提取物的138.63μg/ ml的值,乙酸乙酯提取物和IC_(50)值为二萜类化合物DS-01化合物的191.82μg/ ml。分子对接的结果表明,提取物和DS-01二萜类的活性化合物能够在与受体与受体之间的配体之间形成氢键,但与氨基糖相比,较少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号